TULLIS JAMES L L

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 50% 68% 82%
Transactions
39 15% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 35%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
TULLIS JAMES L L's trades of Alphatec Holdings Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-13 2023-09-11
S Sale
86,932 -12.5%
259.99
US$2,902,505 		86,932 -12.5% 259.99 US$2,902,505
2023-09-13 2023-09-11
S Sale
76,831 -1.0%
499.01
US$1,697,917 		76,831 -1.0% 499.01 US$1,697,917
2023-09-11 2023-09-11
PrS Proposed sale
40,886
253.84
US$1,731,929 		40,886 253.84 US$1,731,929
2023-06-20 2023-06-15
US Exagen Inc (XGN)
B Purchase
167 +0.0%
3.11
US$519 		167 +0.0% 3.11 US$519
2023-03-09 2023-03-08
S Sale
30,000 -6.0%
16.12
US$483,600 		30,000 -6.0% 16.12 US$483,600
2022-12-20 2022-12-16
S Sale
50,000 -9.1%
10.59
US$529,500 		50,000 -9.1% 10.59 US$529,500
2022-06-15 2022-06-15
B Purchase
7,500 +4.2%
6.76
US$50,700 		7,500 +4.2% 6.76 US$50,700
2022-04-11 2022-04-07
S Sale
39,209 -3.8%
12.99
US$509,325 		39,209 -3.8% 12.99 US$509,325
2022-04-11 2022-04-07
S Sale
28,481 -4.9%
12.99
US$369,968 		28,481 -4.9% 12.99 US$369,968
2022-04-11 2022-04-07
S Sale
1,630 -1.0%
12.99
US$21,174 		1,630 -1.0% 12.99 US$21,174
2021-12-13 2021-12-10
S Sale
55,000 -10.5%
11.65
US$640,750 		55,000 -10.5% 11.65 US$640,750
2021-12-13 2021-12-09
S Sale
20,000 -3.7%
11.78
US$235,600 		20,000 -3.7% 11.78 US$235,600
2021-11-29 2021-11-24
US Crane NXT Co (CXT)
S Sale
2,000 -27.6%
104.71
US$209,420 		2,000 -27.6% 104.71 US$209,420
2021-08-04 2021-08-04
US Exagen Inc (XGN)
PlS Planned sale
2,100 -0.1%
11.39
US$23,917 		2,100 -0.1% 11.39 US$23,917
2021-08-04 2021-08-03
US Exagen Inc (XGN)
PlS Planned sale
4,300 -0.3%
11.77
US$50,618 		4,300 -0.3% 11.77 US$50,618
2021-08-04 2021-08-02
US Exagen Inc (XGN)
PlS Planned sale
1,800 -0.1%
11.92
US$21,454 		1,800 -0.1% 11.92 US$21,454
2021-06-29 2021-06-29
US Exagen Inc (XGN)
PlS Planned sale
5,379 -0.4%
14.67
US$78,910 		5,379 -0.4% 14.67 US$78,910
2021-06-29 2021-06-28
US Exagen Inc (XGN)
PlS Planned sale
10,858 -0.7%
14.98
US$162,696 		10,858 -0.7% 14.98 US$162,696
2021-06-29 2021-06-25
US Exagen Inc (XGN)
PlS Planned sale
8,763 -0.6%
16.03
US$140,503 		8,763 -0.6% 16.03 US$140,503
2021-03-11 2021-03-09
S Sale
22,500 -4.0%
16.24
US$365,400 		22,500 -4.0% 16.24 US$365,400
2021-03-01 2021-02-26
US Crane NXT Co (CXT)
S Sale
1,115 -18.2%
84.47
US$94,184 		1,115 -18.2% 84.47 US$94,184
2021-02-25 2021-02-23
S Sale
93,483 -5.9%
16.51
US$1,543,404 		93,483 -5.9% 16.51 US$1,543,404
2021-02-25 2021-02-23
S Sale
67,906 -10.7%
16.51
US$1,121,128 		67,906 -10.7% 16.51 US$1,121,128
2021-02-25 2021-02-23
S Sale
3,887 -2.6%
16.51
US$64,174 		3,887 -2.6% 16.51 US$64,174
2021-02-08 2021-02-05
US Exagen Inc (XGN)
PlS Planned sale
3,000 -12.3%
17.00
US$51,000 		3,000 -12.3% 17.00 US$51,000
2021-01-20 2021-01-19
US Exagen Inc (XGN)
PlS Planned sale
257 -1.0%
15.56
US$3,998 		257 -1.0% 15.56 US$3,998
2021-01-20 2021-01-15
US Exagen Inc (XGN)
PlS Planned sale
1,014 -4.0%
15.51
US$15,725 		1,014 -4.0% 15.51 US$15,725
2021-01-15 2021-01-13
US Exagen Inc (XGN)
PlS Planned sale
4,000 -13.5%
15.58
US$62,320 		4,000 -13.5% 15.58 US$62,320
2021-01-15 2021-01-13
US Exagen Inc (XGN)
PlS Planned sale
1,729 -5.5%
15.74
US$27,214 		1,729 -5.5% 15.74 US$27,214
2020-12-15 2020-12-15
US Exagen Inc (XGN)
S Sale
12,000 -0.8%
12.23
US$146,726 		12,000 -0.8% 12.23 US$146,726
2020-12-14 2020-12-11
US Exagen Inc (XGN)
S Sale
7,500 -0.5%
13.04
US$97,774 		7,500 -0.5% 13.04 US$97,774
2020-12-14 2020-12-10
US Exagen Inc (XGN)
S Sale
10,000 -0.6%
14.03
US$140,300 		10,000 -0.6% 14.03 US$140,300
2020-11-12 2020-11-09
US Exagen Inc (XGN)
PlS Planned sale
882 -2.7%
16.21
US$14,293 		882 -2.7% 16.21 US$14,293
2020-10-19 2020-10-19
US Exagen Inc (XGN)
PlS Planned sale
198 -0.6%
16.02
US$3,171 		198 -0.6% 16.02 US$3,171
2020-10-19 2020-10-16
US Exagen Inc (XGN)
PlS Planned sale
2,104 -6.1%
16.25
US$34,180 		2,104 -6.1% 16.25 US$34,180
2020-10-19 2020-10-15
US Exagen Inc (XGN)
PlS Planned sale
4,316 -11.1%
14.88
US$64,226 		4,316 -11.1% 14.88 US$64,226
2020-09-14 2020-09-11
US Exagen Inc (XGN)
S Sale
15,000 -0.9%
12.40
US$186,000 		15,000 -0.9% 12.40 US$186,000
2020-08-18 2020-08-18
US Exagen Inc (XGN)
S Sale
2,082 -0.1%
14.52
US$30,221 		2,082 -0.1% 14.52 US$30,221
2020-08-18 2020-08-14
US Exagen Inc (XGN)
S Sale
1,398 -3.5%
16.95
US$23,697 		1,398 -3.5% 16.95 US$23,697
2020-08-18 2020-08-14
US Exagen Inc (XGN)
S Sale
11,507 -0.7%
16.95
US$195,052 		11,507 -0.7% 16.95 US$195,052
2020-06-18 2020-06-16
S Sale
38,000 -5.0%
5.15
US$195,700 		38,000 -5.0% 5.15 US$195,700
2020-06-11 2020-06-09
US Exagen Inc (XGN)
S Sale
4,782 -0.3%
12.91
US$61,735 		4,782 -0.3% 12.91 US$61,735
2020-06-11 2020-06-09
US Exagen Inc (XGN)
S Sale
578 -1.4%
12.77
US$7,383 		578 -1.4% 12.77 US$7,383
2020-06-11 2020-06-09
US Exagen Inc (XGN)
S Sale
1,522 -0.1%
12.77
US$19,440 		1,522 -0.1% 12.77 US$19,440
2020-05-29 2020-05-28
US Exagen Inc (XGN)
S Sale
848 -2.0%
11.93
US$10,117 		848 -2.0% 11.93 US$10,117